$109.50
4.944.72%
Ult. Agg.: Nov 10, 4:22 PM
Oruka Therapeutics (ORKA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.63 | $-0.50 | $-0.53 | $-0.61 |
| Actual | $-0.63 | $-0.55 | $-0.48 | $-0.45 |
| Surprise | 0.00% | -10.0% | +9.43% | +26.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.68 | $-0.71 | $-0.68 | $-0.69 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $-0.63 | $-0.63 | 0.00 % |
| Q2 | Aug 10, 2026 | $-0.55 | $-0.50 | -10.0 % |
| Q1 | May 13, 2026 | $-0.48 | $-0.53 | 9.43 % |
| Q4 | Mar 12, 2026 | $-0.45 | $-0.61 | 26.2 % |